含西地那非成分的性保健品定性问题研究

Qualitative research on sildenafil-containing sexual medicine

近年来,司法实践中的含西地那非成分的性保健品定性争议始终存在。此类性保健品含有一定量的西地那非成分,可以治疗男性性功能障碍。不能仅因其由食品原料与有毒、有害的非食品原料组成,便归类于有毒、有害食品。2019年《药品管理法》修订后,“假药”范围缩小,性保健品与假药概念不再兼容,《刑法》丧失规制性保健品的正当依据。《刑法修正案(十一)》发布后,增设“妨害药品管理秩序罪”,将性保健品定性为未取得相关批准文件而生产、销售的药品,符合《刑法》解释原则的要求,缓解了行刑衔接矛盾,有利于保护药品管理秩序与公众生命健康安全。

In recent years,disputes over the qualitative nature of sildenafil-containing sexual medicine have always existed in judicial practice.Such sexual medicines contain sildenafil ingredients,which can treat male sexual dysfunction.They cannot be classified as toxic and harmful foods only because they are composed of food materials and toxic and harmful non-food materials.After the revision of the Drug Administration Law in 2019,the scope of"counterfeit drugs"was reduced,the concept of sexual medicines and counterfeit drugs was no longer compatible,and the Criminal Law lost the legitimate basis for regulating sexual medicines.After the"Criminal Law Amendment(11)"was issued,the"crime of disrupting the order of drug management"was added.Sexual medicines defined as drugs that‘produced and sold without obtaining relevant approval documents’can conform to the requirements of the principles of construction of Criminal Law,ease the connection of criminal law and administrative law and can protect the order of drug management and the health and safety of the public.